{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T06:43:41Z","timestamp":1772433821532,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.ahj.2004.03.025","type":"journal-article","created":{"date-parts":[[2004,6,23]],"date-time":"2004-06-23T10:58:07Z","timestamp":1087988287000},"page":"172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension"],"prefix":"10.1016","volume":"148","author":[{"given":"C","family":"Napoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Sica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"de Nigris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Pignalosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.J","family":"Ignarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2004.03.025_BIB1","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI115499","article-title":"Role of oxidized LDL in atherogenesis","volume":"88","author":"Witztum","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2004.03.025_BIB2","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI119813","article-title":"Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia","volume":"100","author":"Napoli","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2004.03.025_BIB3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(99)02131-5","article-title":"Influence of maternal hypercholesterolemia during pregnancy on progression of early atherosclerotic lesions in childhood","volume":"354","author":"Napoli","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.03.025_BIB4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0025-6196(11)62413-0","article-title":"Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia","volume":"76","author":"Napoli","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ahj.2004.03.025_BIB5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ahj.2004.03.025_BIB6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/jcb.1198","article-title":"Multiple role of reactive oxygen species in the arterial wall","volume":"82","author":"Napoli","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ahj.2004.03.025_BIB7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1471-4914(03)00139-4","article-title":"Oxidation-sensitive mechanisms, vascular apoptosis, and atherosclerosis","volume":"9","author":"de Nigris","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ahj.2004.03.025_BIB8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00004872-199310000-00015","article-title":"Low-density lipoprotein oxidation in essential hypertension","volume":"11","author":"Maggi","year":"1993","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2004.03.025_BIB9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0021-9150(94)90143-0","article-title":"LDL isolated from patients with essential hypertension exhibit increased propensity for oxidation and enhanced uptake by macrophages","volume":"107","author":"Keidar","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2004.03.025_BIB10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004872-199501000-00019","article-title":"Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension","volume":"13","author":"Maggi","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2004.03.025_BIB11","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00004872-200108000-00005","article-title":"Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients","volume":"19","author":"Taddei","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2004.03.025_BIB12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000060135","article-title":"Efficacy of ACE inhibitor (captopril) on glomerular antioxidant enzyme activity and hypertension in diabetic hypertensive rats","volume":"134","author":"Shou","year":"2001","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB13","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/01.STR.30.9.1907","article-title":"1,4-Dihydropyridine calcium-channel blockers inhibit plasma and LDL oxidation, formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats","volume":"30","author":"Napoli","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2004.03.025_BIB14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00005344-199804000-00011","article-title":"Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein e deficient mice","volume":"31","author":"Hayek","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0306-3623(99)00043-9","article-title":"Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in Watanabe heritable hyperlipidemic rabbits","volume":"33","author":"Napoli","year":"1999","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0008-6363(99)00239-4","article-title":"The angiotensin-converting enzyme inhibitor, fosinopril and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure, in apolipoprotein E deficient mice","volume":"44","author":"Hayek","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2004.03.025_BIB17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00005344-200001000-00008","article-title":"Attenuation of atherosclerosis in apolipoproteinE-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin","volume":"35","author":"Keidar","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-5273(01)00542-3","article-title":"Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors inhibit susceptibility of LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice","volume":"81","author":"de Nigris","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0021-9150(01)00621-9","article-title":"Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis","volume":"161","author":"Hayek","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2004.03.025_BIB20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/00005344-199912000-00016","article-title":"Nitric oxide as a signaling molecule in the vascular system","volume":"34","author":"Ignarro","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB21","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.ATV.20.9.2032","article-title":"Does ADMA cause endothelial dysfunction?","volume":"20","author":"Cooke","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.HYP.29.1.242","article-title":"Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension","volume":"29","author":"Matsuoka","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2004.03.025_BIB23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.025_BIB24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0895-7061(99)00042-4","article-title":"Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension","volume":"12","author":"Borghi","year":"1999","journal-title":"Am J Hypertension"},{"key":"10.1016\/j.ahj.2004.03.025_BIB25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1067\/mhj.2003.24","article-title":"Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction","volume":"145","author":"Borghi","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2004.03.025_BIB26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0002-8703(97)70155-8","article-title":"Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia","volume":"133","author":"Napoli","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2004.03.025_BIB27","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.1073\/pnas.192244499","article-title":"Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice","volume":"99","author":"Napoli","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ahj.2004.03.025_BIB28","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.CIR.101.8.856","article-title":"Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension","volume":"101","author":"Fujiwara","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.025_BIB29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/01.HYP.15.3.327","article-title":"Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit","volume":"15","author":"Chobanian","year":"1990","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2004.03.025_BIB30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00005344-199000005-00010","article-title":"Effects of captopril on atherosclerosis in cynomolgus monkeys","volume":"15","author":"Aberg","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB31","first-page":"S178","article-title":"Angiotensin converting enzyme inhibition-induced changes in patterns of hemodynamics, aorta viscoelasticity, arterial histopathology and endothelial cholesterol fluxes of atherosclerotic minipigs","volume":"9","author":"Rolland","year":"1991","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2004.03.025_BIB32","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/01.ATV.13.8.1125","article-title":"ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries","volume":"13","author":"Charpiot","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.ahj.2004.03.025_BIB33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0021-9150(94)90037-X","article-title":"Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters","volume":"108","author":"Kowala","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2004.03.025_BIB34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9150(98)00309-8","article-title":"Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits","volume":"143","author":"Li","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2004.03.025_BIB35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/01.RES.68.2.450","article-title":"Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall","volume":"68","author":"Daemen","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2004.03.025_BIB36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00005344-199602000-00002","article-title":"Fosinopril reduces ADP- induced platelet aggregation in hypertensive patients","volume":"27","author":"Keidar","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB37","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0002-9440(10)65697-0","article-title":"ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis","volume":"153","author":"Hernandez-Presa","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/01.HYP.36.1.103","article-title":"Molecular plasticity of vascular wall during NG-nitro-l-arginine methyl ester-induced hypertension modulation of proinflammatory signals","volume":"36","author":"Gonzalez","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2004.03.025_BIB39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0021-9150(01)00621-9","article-title":"Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis","volume":"161","author":"Hayek","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2004.03.025_BIB40","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/sj.bjp.0703498","article-title":"Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure","volume":"130","author":"Buikema","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0895-7061(02)02995-3","article-title":"Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species","volume":"15","author":"Cominacini","year":"2002","journal-title":"Am J Hypertens"},{"issue":"Suppl 2","key":"10.1016\/j.ahj.2004.03.025_BIB42","first-page":"115S","article-title":"Comparison in vitro, ex vivo and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE)","volume":"28","author":"Cushman","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00005344-199203000-00005","article-title":"Antioxidant effects of angiotensin-converting enzyme inhibitors: free radicals and oxidant scavenging are sulfhydryl dependents, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors","volume":"19","author":"Chopra","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0021-9150(02)00011-4","article-title":"The use of antioxidants supplements in coronary heart disease","volume":"164","author":"Kritharides","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2004.03.025_BIB45","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(02)08154-0","article-title":"Effect of vitamin C and E on progression of transplant-associated arteriosclerosis","volume":"359","author":"Fang","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.03.025_BIB46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM200001203420302","article-title":"Vitamin E supplementation and cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.025_BIB47","first-page":"233","article-title":"Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers","volume":"52","author":"Marzo","year":"2002","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ahj.2004.03.025_BIB48","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/0006-2952(90)90250-O","article-title":"Protective effects of sulfhydryl-containing angiotensin-converting enzyme inhibitors against free radical injury in endothelial cells","volume":"40","author":"Mak","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0021-9150(94)05514-J","article-title":"Angiotensin II stimulates macrophage-mediated lipid peroxidation of LDL","volume":"115","author":"Keidar","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2004.03.025_BIB50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.ATV.16.1.97","article-title":"Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor leading to cellular cholesterol accumulation","volume":"16","author":"Keidar","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0168-8227(99)00149-7","article-title":"Oxidation of low-density lipoprotein in normotensive type 2 diabetic patients","volume":"48","author":"Rachmani","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ahj.2004.03.025_BIB52","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/diacare.26.6.1862","article-title":"Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction","volume":"26","author":"Borghi","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2004.03.025_BIB53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/niox.2001.0337","article-title":"Nitric oxide and atherosclerosis","volume":"5","author":"Napoli","year":"2001","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ahj.2004.03.025_BIB54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.43.100901.140226","article-title":"Nitric oxide-releasing drugs","volume":"47","author":"Napoli","year":"2003","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2003.10.002","article-title":"The effect of angiotensin converting enzyme inhibition on endothelial function and oxidant stress","volume":"482","author":"Scribner","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199007053230105","article-title":"Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension","volume":"323","author":"Panza","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.025_BIB57","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0735-1097(00)00736-1","article-title":"Randomized, placebo-controlled trial of the angiotensin converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease","volume":"36","author":"MacMahon","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2004.03.025_BIB58","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archinte.163.10.1155","article-title":"Renin-angiotensin system and atherothrombotic disease","volume":"163","author":"Jacoby","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2004.03.025_BIB59","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0731-7085(00)00342-3","article-title":"Development and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules","volume":"23","author":"Hogan","year":"2000","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.ahj.2004.03.025_BIB60","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0022-3565(25)10737-4","article-title":"Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury","volume":"262","author":"Gillis","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ahj.2004.03.025_BIB61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304001516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304001516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:04:01Z","timestamp":1757567041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870304001516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0002870304001516"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2004.03.025","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2004.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}